Keegan BM - Search Results

1

Frequency of demyelinating disease activity following immune checkpoint inhibitor cancer immunotherapy.

Hasan S, Zorio O, Keegan BM, Weinshenker BG, Flanagan EP, Tobin WO, Kantarci OH, Toledano M, Pittock SJ, Lopez-Chiriboga S, Zekeridou A, Valencia-Sanchez C. Hasan S, et al. Among authors: keegan bm. J Neurol. 2023 Oct;270(10):4707-4712. doi: 10.1007/s00415-023-11933-6. Epub 2023 Aug 19. J Neurol. 2023. PMID: 37597071 No abstract available.

2

Contrasting effects of IFNbeta and IVIG in children with central and peripheral demyelination.

Pirko I, Kuntz NL, Patterson M, Keegan BM, Weinshenker BG, Rodriguez M. Pirko I, et al. Among authors: keegan bm. Neurology. 2003 May 27;60(10):1697-9. doi: 10.1212/01.wnl.0000064163.94122.eb. Neurology. 2003. PMID: 12771272

3

A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis.

Wingerchuk DM, Benarroch EE, O'Brien PC, Keegan BM, Lucchinetti CF, Noseworthy JH, Weinshenker BG, Rodriguez M. Wingerchuk DM, et al. Among authors: keegan bm. Neurology. 2005 Apr 12;64(7):1267-9. doi: 10.1212/01.WNL.0000156803.23698.9A. Neurology. 2005. PMID: 15824361 Clinical Trial.

4

Multiple sclerosis, brain radiotherapy, and risk of neurotoxicity: the Mayo Clinic experience.

Miller RC, Lachance DH, Lucchinetti CF, Keegan BM, Gavrilova RH, Brown PD, Weinshenker BG, Rodriguez M. Miller RC, et al. Among authors: keegan bm. Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1178-86. doi: 10.1016/j.ijrobp.2006.06.014. Epub 2006 Sep 11. Int J Radiat Oncol Biol Phys. 2006. PMID: 16965867 Clinical Trial.

5

Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations.

Pittock SJ, Reindl M, Achenbach S, Berger T, Bruck W, Konig F, Morales Y, Lassmann H, Bryant S, Moore SB, Keegan BM, Lucchinetti CF. Pittock SJ, et al. Among authors: keegan bm. Mult Scler. 2007 Jan;13(1):7-16. doi: 10.1177/1352458506072189. Mult Scler. 2007. PMID: 17294606

6

Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin G.

Keegan BM, Pittock SJ, Lennon VA. Keegan BM, et al. Ann Neurol. 2008 Apr;63(4):531-4. doi: 10.1002/ana.21324. Ann Neurol. 2008. PMID: 18306241

7

Laquinimod, a new oral drug for multiple sclerosis.

Keegan BM, Weinshenker BG. Keegan BM, et al. Lancet. 2008 Jun 21;371(9630):2059-60. doi: 10.1016/S0140-6736(08)60894-6. Lancet. 2008. PMID: 18572062 No abstract available.

8

Treatment of central neurogenic hyperventilation with plasma exchange.

Keegan BM, Weinshenker BG. Keegan BM, et al. J Neurol. 2008 Aug;255(8):1274. doi: 10.1007/s00415-008-0886-7. Epub 2008 Jul 7. J Neurol. 2008. PMID: 18592127 No abstract available.

9

Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease.

Siva A, Saip S, Altintas A, Jacob A, Keegan BM, Kantarci OH. Siva A, et al. Among authors: keegan bm. Mult Scler. 2009 Aug;15(8):918-27. doi: 10.1177/1352458509106214. Mult Scler. 2009. PMID: 19667020

10

Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.

Magaña SM, Pittock SJ, Lennon VA, Keegan BM, Weinshenker BG, Lucchinetti CF. Magaña SM, et al. Among authors: keegan bm. Arch Neurol. 2009 Aug;66(8):964-6. doi: 10.1001/archneurol.2009.152. Arch Neurol. 2009. PMID: 19667216 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters